Clinical Trials Browser

Phase 1/2 × Genetic Engineering × Clear all

NCT03596086 2024-11-25

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

Phase 1/2 Recruiting

Astrocytoma, Glioblastoma